+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
From
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2024 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Acne Vulgaris - Epidemiology Forecast - 2034 - Product Thumbnail Image

Acne Vulgaris - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 119 Pages
  • Global
From
From
DUPIXENT Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

DUPIXENT Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Scars - Pipeline Insight, 2024 - Product Thumbnail Image

Scars - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more